Barbara A. Pahud, MD, MPH
Research Director, Pediatric Infectious Diseases; Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine; Clinical Associate Professor of Pediatrics, University of Kansas School of MedicineFull Biography
Children’s Mercy recently received a 1-year, $50,000 GlaxoSmithKline Center for Medical Education Vaccine Preventable Diseases grant, which will be used by Barbara Pahud, MD, MPH, Infectious Diseases, to update and expand her vaccine education program and app.
This award is in conjunction with the Pediatric Infectious Diseases Society (PIDS) and awards from multiple other industry collaborators (GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, Seqirus, and Valneva). All awards will be used for the “Comprehensive Vaccine Education from Training to Practice” program, which includes the Collaboration for Vaccine Education and Research (CoVER) Vaccine Modules and The Vaccine Handbook App (TVH App). Children's Mercy faculty involved include Dr. Kadriye Lewis, Dr. Sharon Humiston, Dr. Barbara Pahud, and Shannon Clark.
“The gains that have been achieved in preventing disease through vaccination are threatened by public complacency, vaccine hesitancy, knowledge gaps, and a reluctance on the part of providers to take strong advocacy positions,” wrote Dr. Pahud. “The goal of this program is to continue to provide a comprehensive vaccine education program to remedy knowledge gaps along the spectrum of professional development, beginning in residency training and extending into the practice years.”
The new goals of this program are to produce an updated edition of TVH App (by Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine) and make it available free of charge and to also create an expanded version of the CoVER curriculum for pediatric and family medicine trainees.
“By empowering providers to meet the contemporary challenges in vaccine delivery across the professional development spectrum, from trainee to established provider, the PIDS program will result in high levels of competency in vaccine practice that will help to keep vaccine-preventable diseases at bay and improve public health,” said Dr. Pahud.